Literature DB >> 21148305

A Cdc48p-associated factor modulates endoplasmic reticulum-associated degradation, cell stress, and ubiquitinated protein homeostasis.

Joseph R Tran1, Lauren R Tomsic, Jeffrey L Brodsky.   

Abstract

The hexameric AAA-ATPase, Cdc48p, catalyzes an array of cellular activities, including endoplasmic reticulum (ER)-associated degradation (ERAD), ER/Golgi membrane dynamics, and DNA replication. Accumulating data suggest that unique Cdc48p partners, such as Npl4p-Ufd1p and Ubx1p/Shp1p (p47 in vertebrates), target Cdc48p for these diverse functions. Other Cdc48p-associated proteins have been identified, but the interplay among these factors and their activities is largely cryptic. We now report on a previously uncharacterized Cdc48p-associated protein, Ydr049p, also known as Vms1p, which binds Cdc48p at both the ER membrane and in the cytosol under non-stressed conditions. Loss of YDR049 modestly slows the degradation of the cystic fibrosis transmembrane conductance regulator but does not impede substrate ubiquitination, suggesting that Ydr049p acts at a postubiquitination step in the ERAD pathway. Consistent with Ydr049p playing a role in Cdc48p substrate release, ydr049 mutant cells accumulate Cdc48p-bound ubiquitinated proteins at the ER membrane. Moreover, YDR049 interacts with genes encoding select UBX (ubiquitin regulatory X) and UFD (ubiquitin fusion degradation) proteins, which are Cdc48p partners. Exacerbated growth defects are apparent in some of the mutant combinations, and synergistic effects on the degradation of cystic fibrosis transmembrane conductance regulator and CPY*, which is a soluble ERAD substrate, are evident in specific ydr049-ufd and -ubx mutants. These data suggest that Ydr049p acts in parallel with Cdc48p partners to modulate ERAD and other cellular activities.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21148305      PMCID: PMC3037687          DOI: 10.1074/jbc.M110.179259

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  83 in total

1.  The AAA ATPase Cdc48/p97 and its partners transport proteins from the ER into the cytosol.

Authors:  Y Ye; H H Meyer; T A Rapoport
Journal:  Nature       Date:  2001-12-06       Impact factor: 49.962

2.  Mobilization of processed, membrane-tethered SPT23 transcription factor by CDC48(UFD1/NPL4), a ubiquitin-selective chaperone.

Authors:  M Rape; T Hoppe; I Gorr; M Kalocay; H Richly; S Jentsch
Journal:  Cell       Date:  2001-11-30       Impact factor: 41.582

3.  Hsp70 molecular chaperone facilitates endoplasmic reticulum-associated protein degradation of cystic fibrosis transmembrane conductance regulator in yeast.

Authors:  Y Zhang; G Nijbroek; M L Sullivan; A A McCracken; S C Watkins; S Michaelis; J L Brodsky
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

4.  Membrane and soluble substrates of the Doa10 ubiquitin ligase are degraded by distinct pathways.

Authors:  Tommer Ravid; Stefan G Kreft; Mark Hochstrasser
Journal:  EMBO J       Date:  2006-01-26       Impact factor: 11.598

5.  AAA-ATPase p97/Cdc48p, a cytosolic chaperone required for endoplasmic reticulum-associated protein degradation.

Authors:  Efrat Rabinovich; Anat Kerem; Kai-Uwe Fröhlich; Noam Diamant; Shoshana Bar-Nun
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

6.  RPN4 is a ligand, substrate, and transcriptional regulator of the 26S proteasome: a negative feedback circuit.

Authors:  Y Xie; A Varshavsky
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

7.  HRD4/NPL4 is required for the proteasomal processing of ubiquitinated ER proteins.

Authors:  N W Bays; S K Wilhovsky; A Goradia; K Hodgkiss-Harlow; R Y Hampton
Journal:  Mol Biol Cell       Date:  2001-12       Impact factor: 4.138

8.  Doa1 is a Cdc48 adapter that possesses a novel ubiquitin binding domain.

Authors:  James E Mullally; Tatiana Chernova; Keith D Wilkinson
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

9.  A complex of mammalian ufd1 and npl4 links the AAA-ATPase, p97, to ubiquitin and nuclear transport pathways.

Authors:  H H Meyer; J G Shorter; J Seemann; D Pappin; G Warren
Journal:  EMBO J       Date:  2000-05-15       Impact factor: 11.598

10.  Global landscape of protein complexes in the yeast Saccharomyces cerevisiae.

Authors:  Nevan J Krogan; Gerard Cagney; Haiyuan Yu; Gouqing Zhong; Xinghua Guo; Alexandr Ignatchenko; Joyce Li; Shuye Pu; Nira Datta; Aaron P Tikuisis; Thanuja Punna; José M Peregrín-Alvarez; Michael Shales; Xin Zhang; Michael Davey; Mark D Robinson; Alberto Paccanaro; James E Bray; Anthony Sheung; Bryan Beattie; Dawn P Richards; Veronica Canadien; Atanas Lalev; Frank Mena; Peter Wong; Andrei Starostine; Myra M Canete; James Vlasblom; Samuel Wu; Chris Orsi; Sean R Collins; Shamanta Chandran; Robin Haw; Jennifer J Rilstone; Kiran Gandi; Natalie J Thompson; Gabe Musso; Peter St Onge; Shaun Ghanny; Mandy H Y Lam; Gareth Butland; Amin M Altaf-Ul; Shigehiko Kanaya; Ali Shilatifard; Erin O'Shea; Jonathan S Weissman; C James Ingles; Timothy R Hughes; John Parkinson; Mark Gerstein; Shoshana J Wodak; Andrew Emili; Jack F Greenblatt
Journal:  Nature       Date:  2006-03-22       Impact factor: 49.962

View more
  20 in total

1.  The Cdc48 protein and its cofactor Vms1 are involved in Cdc13 protein degradation.

Authors:  Guem Hee Baek; Haili Cheng; Ikjin Kim; Hai Rao
Journal:  J Biol Chem       Date:  2012-06-20       Impact factor: 5.157

2.  A conserved protein with AN1 zinc finger and ubiquitin-like domains modulates Cdc48 (p97) function in the ubiquitin-proteasome pathway.

Authors:  Bebiana Sá-Moura; Minoru Funakoshi; Robert J Tomko; R Jürgen Dohmen; Zhiping Wu; Junmin Peng; Mark Hochstrasser
Journal:  J Biol Chem       Date:  2013-10-11       Impact factor: 5.157

3.  The general definition of the p97/valosin-containing protein (VCP)-interacting motif (VIM) delineates a new family of p97 cofactors.

Authors:  Christopher Stapf; Edward Cartwright; Mark Bycroft; Kay Hofmann; Alexander Buchberger
Journal:  J Biol Chem       Date:  2011-09-06       Impact factor: 5.157

4.  The requirement for Cdc48/p97 in nuclear protein quality control degradation depends on the substrate and correlates with substrate insolubility.

Authors:  Pamela S Gallagher; Sarah V Clowes Candadai; Richard G Gardner
Journal:  J Cell Sci       Date:  2014-02-25       Impact factor: 5.285

5.  Cdc48/p97 segregase is modulated by cyclin-dependent kinase to determine cyclin fate during G1 progression.

Authors:  Eva Parisi; Galal Yahya; Alba Flores; Martí Aldea
Journal:  EMBO J       Date:  2018-06-27       Impact factor: 11.598

6.  The Cdc48-Vms1 complex maintains 26S proteasome architecture.

Authors:  Joseph R Tran; Jeffrey L Brodsky
Journal:  Biochem J       Date:  2014-03-15       Impact factor: 3.857

Review 7.  A Futile Battle? Protein Quality Control and the Stress of Aging.

Authors:  Ryo Higuchi-Sanabria; Phillip Andrew Frankino; Joseph West Paul; Sarah Uhlein Tronnes; Andrew Dillin
Journal:  Dev Cell       Date:  2018-01-22       Impact factor: 12.270

8.  A Proteomic Variant Approach (ProVarA) for Personalized Medicine of Inherited and Somatic Disease.

Authors:  Darren M Hutt; Salvatore Loguercio; Alexandre Rosa Campos; William E Balch
Journal:  J Mol Biol       Date:  2018-06-18       Impact factor: 5.469

9.  Cdc48-associated complex bound to 60S particles is required for the clearance of aberrant translation products.

Authors:  Quentin Defenouillère; Yanhua Yao; John Mouaikel; Abdelkader Namane; Aurélie Galopier; Laurence Decourty; Antonia Doyen; Christophe Malabat; Cosmin Saveanu; Alain Jacquier; Micheline Fromont-Racine
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-11       Impact factor: 11.205

10.  Correcting the F508del-CFTR variant by modulating eukaryotic translation initiation factor 3-mediated translation initiation.

Authors:  Darren M Hutt; Salvatore Loguercio; Daniela Martino Roth; Andrew I Su; William E Balch
Journal:  J Biol Chem       Date:  2018-07-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.